Tissue-specific double gene silencing RNAi expression vector having self-splicing locus
A tissue-specific, expression vector technology, applied in the medical field, can solve problems such as non-tissue-specific effects, limit gene silencing, etc., and achieve the effect of simple construction method and easy operation.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0040] (1) Insertion of the first oligonucleotide with self-cleaving ribozyme sequence:
[0041] In order to facilitate the insertion of the initial vector pEGFP-C1, a Nhe Ⅰ restriction site (GCTAGC) was added to the 5'end of the first cis-acting cis-acting hammerhead ribozyme sequence (SEQ ID NO:1), at the 3'end Add the BglⅡ restriction site (AGATCT), artificially synthesize it, and obtain the first cis-acting non-hook hammerhead shark ribozyme sequence oligonucleotide double-stranded with restriction enzymes Nhe Ⅰ and Bgl Ⅱ , Insert the Nhe Ⅰ and Bgl Ⅱ restriction sites of the original vector pEGFP-C1 to construct the vector pRib (SEQ ID NO: 7);
[0042] (2) Insertion of the second oligonucleotide with self-cleaving ribozyme sequence:
[0043] To facilitate the insertion into the vector pRib, add HindⅢ restriction site (AAGCTT) to the 5'end of the second cis-acting Hammerhead ribozyme sequence (SEQ ID NO:1), and add EcoR Ⅰ restriction to the 3'end Site (GAATTC), artificially synt...
Embodiment 2
[0056] (1) Insertion of the first oligonucleotide with self-cleaving ribozyme sequence:
[0057] In order to facilitate the insertion of the initial vector pEGFP-C1, a Nhe Ⅰ restriction site (GCTAGC) was added to the 5'end of the first cis-acting cis-acting hammerhead ribozyme sequence (SEQ ID NO:1), at the 3'end Add the BglⅡ restriction site (AGATCT), artificially synthesize it, and obtain the first cis-acting non-hook hammerhead shark ribozyme sequence oligonucleotide double-stranded with restriction enzymes Nhe Ⅰ and Bgl Ⅱ , Insert the Nhe Ⅰ and Bgl Ⅱ restriction sites of the original vector pEGFP-C1 to construct the vector pRib (SEQ ID NO: 7);
[0058] (2) Insertion of the second oligonucleotide with self-cleaving ribozyme sequence:
[0059] To facilitate the insertion into the vector pRib, add HindⅢ restriction site (AAGCTT) to the 5'end of the second cis-acting Hammerhead ribozyme sequence (SEQ ID NO:1), and add EcoR Ⅰ restriction to the 3'end Site (GAATTC), artificially synt...
PUM

Abstract
Description
Claims
Application Information

- R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com